|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, August 30, 2013 ) San Diego, California -- NASA scientists, for decades, have researched and utilized validated LED Phototherapy technology to provide pain relief and speed breakthroughs in powerful LED lighting. It required way too much funds and machinery to produce efficient at home and even healthcare office based phototherapy instruments. The necessary light energy output was not possible in a compact, affordable medical device. Thankfully, technology has eventually caught up. We are happy to introduce the TendLite. Which has a powerful 1800 mW output of our therapeutic red light wavelength, the TendLite is an FDA cleared medical device stated to deal with all kinds of Joint Pain.
TendLite has the "Power to Penetrate"
The TendLite is a risk-free, extremely effective way to treat your Joint Pain minus the unwanted effects of drugs or risks of infection and extended recovery time brought on by injectable steroids or surgeries.
While doctors and scientists are most astounded with TendLite's safety and efficacy, many patients will likely be most amazed with the extremely affordable price of this high-tech device. TendLite costs less than two sessions of Physical Rehabilitation, and can be conveniently administered, without a doctor, at your home on your own schedule or on the go.
Costly, addicting and potentially dangerous pain killers can be a thing of the past!
TendLite has the "Power to Penetrate" deeply into the tissue, muscles, tendons and joints to treat and relieve your pain. Watch out for low quality devices that contains a number of low powered, low quality red light bulbs. They don't have the "Power to Penetrate" that TendLite has.
The "Power to Penetrate" is how TendLite provides the best results.
About TendLite
The TendLite is a safe, extremely effective way to treat your joint pain without the side effects of drugs or risks of infection and prolonged down time caused by injectable steroids or surgeries.
TendLite
Ken
8582746524
pr@tendlite.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
